Form 4: Nutanix CLO Sells Shares Under 10b5-1 Plan

Nutanix Chief Legal Officer Brian Martin sold 10,241 shares of Class A Common Stock for a weighted average price of $76.5288 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Brian Martin, Chief Legal Officer of Nutanix, Inc. (NTNX), reported a sale of company stock.
• The transaction involved the disposition of 10,241 shares of Class A Common Stock.
• The shares were sold at a weighted average price of $76.5288 per share, with individual sales ranging from $76.24 to $76.88.
• The sale was executed on September 30, 2025, pursuant to a Rule 10b5-1 trading plan adopted on July 1, 2025.
• Following this transaction, Brian Martin directly beneficially owns 5,166 shares of Class A Common Stock.
• The reported beneficial ownership includes 229 shares acquired under the Nutanix, Inc. Employee Stock Purchase Plan on September 22, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine insider transaction executed under a pre-arranged 10b5-1 trading plan, which is not typically indicative of new positive or negative company developments.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reactive sale based on new, non-public information.
• The reporting person acquired 229 shares through the Employee Stock Purchase Plan shortly before the reported sale, demonstrating continued participation in employee ownership programs.

Negatives

• The Chief Legal Officer sold a significant number of shares (10,241 shares), which could be perceived as a reduction in insider holdings, despite the 10b5-1 plan context.

Risks

• Potential for negative investor sentiment if the market misinterprets the 10b5-1 sale as a reactive insider disposition rather than a pre-planned event.

Future Outlook

This insider transaction report does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction under a pre-arranged 10b5-1 plan, which is a common practice among executives in publicly traded technology companies like Nutanix for managing personal stock holdings. It does not provide specific insights into broader industry trends or competitive positioning.

Comparison to Industry Standards

• This filing details a standard insider stock transaction executed under a Rule 10b5-1 plan, a common mechanism used by executives across various industries to sell shares in a compliant manner. There are no specific comparable companies, projects, or results mentioned within this Form 4 to assess against global benchmarks.

Stakeholder Impact

• Shareholders: May observe a reduction in the Chief Legal Officer's direct holdings, though this is mitigated by the pre-planned nature of the 10b5-1 transaction.

Next Steps

• No specific future actions, events, or milestones are mentioned in this insider transaction report.

Key Dates

Keywords

Nutanix, NTNX, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Brian Martin, Chief Legal Officer, Equity Transaction